As shown in Figure S3A, the hepatic SREBP-1c protein, which controls the de novo synthesis of fatty acids, was obviously activated in AF/CSO group; however, the difference in the protein expressions of CD36 and FATP2 in mice livers between AF/CO and AF/CSO groups was not statistically significant. The gene discussed is CD36; the disease is craniosynostosis.